Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness

Shah Chirag P.; Heier Jeffrey S.

首页> 外文期刊>Ophthalmic surgery, lasers & imaging retina >Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness

【24h】

Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness

机译：以前用雷珠单抗和/或贝伐单抗治疗的眼睛中的糖尿病性黄斑水肿的阿柏西普可能会进一步改善黄斑厚度

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND AND OBJECTIVE: To evaluate the short-term anatomic and visual outcomes after aflibercept (Eylea; Regeneron, Tarrytown, NY) in eyes with diabetic macular edema (DME) previously treated with ranibizumab (Lucentis; Genentech, South San Francisco, CA) and/or bevacizumab (Avastin; Genentech, South San Francisco, CA).

机译：背景与目的：评价在接受过兰尼单抗（Lucentis; Genentech，南旧金山，加利福尼亚州）治疗的糖尿病性黄斑水肿（DME）的眼中，接受阿柏西普（Eylea; Regeneron，Tarrytown，NY）后的短期解剖和视觉结果，以及/或贝伐单抗（Avastin; Genentech，南旧金山，加利福尼亚）。

著录项

来源
《Ophthalmic surgery, lasers & imaging retina》 |2016年第9期|共4页
作者
Shah Chirag P.; Heier Jeffrey S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness [J] . Calugaru Dan, Calugaru Mihai Ophthalmic surgery, lasers & imaging retina . 2017,第7期

机译：致编辑的信：以前用Ranibizumab和/或贝伐单抗治疗的眼睛的糖尿病黄斑水肿的AfliBercept可能进一步改善黄斑厚度
2. Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness [J] . Shah Chirag P., Heier Jeffrey S. Ophthalmic surgery, lasers & imaging retina . 2016,第9期

机译：以前用雷珠单抗和/或贝伐单抗治疗的眼睛中的糖尿病性黄斑水肿的阿柏西普可能会进一步改善黄斑厚度
3. Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema [J] . Valérie Sarda, Pauline Eymard, Linda Hrarat, Journal of Ophthalmology . 2020,第1期

机译：Ranibizumab和AfliBelcept对糖尿病性黄斑水肿治疗患者黄斑脉络膜厚度变化的比较
4. Morphology of vascular network in eyes with diabetic macular edema varies based on tolerance of aflibercept treatment interval length: preliminary findings [C] . Prateek Prasanna, Justis Ehlers, Nathaniel Braman, Biomedical Applications in Molecular, Structural, and Functional Imaging . 2019

机译：患有糖尿病黄斑水肿的眼睛中血管网络的形态基于AfliBercept治疗间隔长度的耐受性因耐受性而变化：初步调查结果
5. Structural and Vascular Changes Following Laser for Diabetic Macular Edema. [D] . Leontieva, Elena. 2016

机译：激光治疗糖尿病性黄斑水肿后的结构和血管变化。
6. Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema [O] . Valérie Sarda, Pauline Eymard, Linda Hrarat, 2020

机译：Ranibizumab和AfliBelcept对糖尿病性黄斑水肿治疗患者黄斑脉络膜厚度变化的比较
7. Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab [O] . Neil M. Bressler, Isoken Odia, Maureen Maguire, 2019

机译：在Aflibercept，Bevacibizumab或Ranibizumab中的参与者治疗参与者中患有糖尿病黄斑水肿的视力变化与中央子场厚度之间的关系

Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness

摘要

著录项

相似文献

相关主题

期刊订阅